Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hepatitis B Virus Therapeutic Agent ARB-1740 Has Inhibitory Effect on Hepatitis Delta Virus in a New Dually-Infected Humanized Mouse Model
Xin Ye, Chise Tateno, Emily P. Thi, et al.
ACS Infectious Diseases (2018) Vol. 5, Iss. 5, pp. 738-749
Closed Access | Times Cited: 23

Showing 23 citing articles:

Therapeutic siRNA: state of the art
Bo Hu, Liping Zhong, Yuhua Weng, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 1089
Lipid nanoparticles for nucleic acid delivery: Current perspectives
Eleni Samaridou, James Heyes, Peter Lutwyche
Advanced Drug Delivery Reviews (2020) Vol. 154-155, pp. 37-63
Closed Access | Times Cited: 433
Lipid nanoparticle technology for therapeutic gene regulation in the liver
Dominik Witzigmann, Jayesh A. Kulkarni, Jerry Leung, et al.
Advanced Drug Delivery Reviews (2020) Vol. 159, pp. 344-363
Open Access | Times Cited: 276
Nucleic acid delivery for therapeutic applications
Akash Gupta, Jason L. Andresen, Rajith S. Manan, et al.
Advanced Drug Delivery Reviews (2021) Vol. 178, pp. 113834-113834
Closed Access | Times Cited: 219
Lipid-nanoparticle-enabled nucleic acid therapeutics for liver disorders
Porkizhi Arjunan, Durga Kathirvelu, Gokulnath Mahalingam, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2885-2900
Open Access | Times Cited: 6
Rationale and Application of PEGylated Lipid-Based System for Advanced Target Delivery of siRNA
Xuemei Ge, Lijuan Chen, Bo Zhao, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 33
Quantified integrated hepatitis B virus is related to viral activity in patients with chronic hepatitis B
Robin Erken, Vladimir V. Loukachov, Karel van Dort, et al.
Hepatology (2022) Vol. 76, Iss. 1, pp. 196-206
Open Access | Times Cited: 22
Ionizable drug delivery systems for efficient and selective gene therapy
Yuqi Zhang, Ranran Guo, Yonghu Chen, et al.
Military Medical Research (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 13
Nanostructured Drug Delivery Systems in Immunotherapy: An Updated Overview of Nanotechnology-Based Therapeutic Innovations
George-Alexandru Croitoru, Adelina-Gabriela Niculescu, Dragoș Epistatu, et al.
Applied Sciences (2024) Vol. 14, Iss. 19, pp. 8948-8948
Open Access | Times Cited: 5
Preclinical testing of antiviral siRNA therapeutics delivered in lipid nanoparticles in animal models – a comprehensive review
Yusuf M. Idres, Adi Idris, Wenqing Gao
Drug Delivery and Translational Research (2025)
Open Access
Therapy with murinized tobevibart and elebsiran is efficacious in a liver-chimeric mouse model of HDV infection
Jiayi Zhou, Hannah Kaiser, Eduardo Melani Rocha, et al.
JHEP Reports (2025), pp. 101400-101400
Open Access
Humanized Mice for Infectious and Neurodegenerative disorders
Prasanta K. Dash, Santhi Gorantla, Larisa Y. Poluektova, et al.
Retrovirology (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 29
Gene-Editing and RNA Interference in Treating Hepatitis B: A Review
Nadiia Kasianchuk, Krystyna Dobrowolska, Sofiia Harkava, et al.
Viruses (2023) Vol. 15, Iss. 12, pp. 2395-2395
Open Access | Times Cited: 11
Art of Making Artificial Liver: Depicting Human Liver Biology and Diseases in Mice
Go Sugahara, Yuji Ishida, Jeffrey C. Sun, et al.
Seminars in Liver Disease (2020) Vol. 40, Iss. 02, pp. 189-212
Open Access | Times Cited: 28
New Applications of Lipid and Polymer-Based Nanoparticles for Nucleic Acids Delivery
Adelina-Gabriela Niculescu, Alexandra Cătălina Bîrcă, Alexandru Mihai Grumezescu
Pharmaceutics (2021) Vol. 13, Iss. 12, pp. 2053-2053
Open Access | Times Cited: 26
Recent progress on fluorescent probes for viruses
Siyang Shen, Weilin Xu, Jianxiang Lu, et al.
Chinese Chemical Letters (2023) Vol. 35, Iss. 1, pp. 108360-108360
Open Access | Times Cited: 10
Evaluation of Interfering RNA Efficacy in Treating Hepatitis B: Is It Promising?
Giovana Angelice, Pedro Henrique da Conceição Roque, Guido Valente, et al.
Viruses (2024) Vol. 16, Iss. 11, pp. 1710-1710
Open Access | Times Cited: 3
Advances in Nanoparticle Drug Delivery Systems for Anti-Hepatitis B Virus Therapy: A Narrative Review
Jing Miao, Peng Gao, Qian Li, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11227-11227
Open Access | Times Cited: 13
Inspecting the Ribozyme Region of Hepatitis Delta Virus Genotype 1: Conservation and Variability
Beatriz Pacín Ruiz, María Francesca Cortese, David Tabernero, et al.
Viruses (2022) Vol. 14, Iss. 2, pp. 215-215
Open Access | Times Cited: 6
In Vivo Models of HDV Infection: Is Humanizing NTCP Enough?
Katja Giersch, Maura Dandri
Viruses (2021) Vol. 13, Iss. 4, pp. 588-588
Open Access | Times Cited: 8
Anti‐DNAVirus Agents
Antonı́n Holý, Erik De Clercq
Burger's Medicinal Chemistry and Drug Discovery (2010), pp. 219-256
Closed Access | Times Cited: 3
創薬ツールとしてのヒト肝細胞キメラマウス
Takashi Shimada
Folia Pharmacologica Japonica (2023) Vol. 158, Iss. 6, pp. 483-489
Closed Access
Anti‐DNA Virus Agents
Piet Herdewijn, Weijie Gu, Erik De Clercq
Burger's Medicinal Chemistry and Drug Discovery (2021), pp. 1-41
Closed Access
Page 1

Scroll to top